Understanding Mental Health in Women

Women’s mental health deserves attention at every stage of life. Depression, anxiety, trauma, eating disorders, and other conditions can affect relationships, work, parenting, physical health, and a person’s sense of self. ADHD and autism may also go unrecognized for years, especially when a girl or woman learns to hide her difficulties.

Effective care begins with understanding the individual. At Turned Leaf Psychiatry, we take symptoms seriously and help patients work toward an accurate diagnosis and a treatment plan that fits their lives. Hormones, sleep, medical conditions, family history, trauma, and daily demands all deserve a place in that conversation.

How common are mental health conditions in women

The estimates below describe different populations and time periods. A two-week symptom screen, a past-year diagnosis, and a lifetime diagnosis measure different things. They should not be ranked against one another or added together: one person may experience several conditions. Most figures are from the United States; PMDD and schizophrenia estimates identified as global are exceptions.

This article includes peer-reviewed studies published within the last three years, from October 2, 2023, through October 2, 2026. Some additional sex-specific estimates come from older national surveys still reported by NIMH. These are labeled as historical benchmarks rather than presented as 2026 prevalence.

Condition	Female prevalence or rate	Population and interpretation
Depression symptoms	16.0% of females age 12 and older; 26.5% at ages 12–19	U.S. 2021–2023 data, reported in 2025. PHQ-9 score ≥10 during the past two weeks; a positive screen is not a confirmed diagnosis (CDC NCHS, 2025).
Anxiety disorders	23.4% of adult women in the past year	Historical U.S. 2001–2003 survey; men: 14.3%. The older category included PTSD and OCD, which are separate categories today (NIMH, n.d.-a).
PMDD	1.6% with confirmed PMDD in community samples	2024 global meta-analysis. Confirmed prevalence across all samples was 3.2%; estimates depend on how diagnosis is established (Reilly et al., 2024).
Eating disorders	Binge eating: 1.6% past year; bulimia: 0.5% past year; anorexia: 0.9% lifetime	Adult women, historical U.S. 2001–2003 data. These are separate disorders and time windows, not a combined total (NIMH, n.d.-b).
Bipolar disorder	2.8% of adult women in the past year	Historical U.S. 2001–2003 survey; men: 2.9%. The survey used a broad bipolar spectrum definition (NIMH, n.d.-c).
Borderline personality disorder	6.2% lifetime in one national survey of women	U.S. 2004–2005 NESARC data, published in 2008; men: 5.6%, with no statistically significant sex difference. A separate survey estimated 1.4% past-year BPD overall. Methods differ substantially (Grant et al., 2008; NIMH, n.d.-d).
ADHD	3.2% of women ages 18–44	Historical U.S. 2001–2003 estimate of current adult ADHD; men: 5.4%. A newer 2024 CDC report found 6.0% current diagnosed ADHD among all adults, not specifically women (NIMH, n.d.-e; CDC, 2024).
Autism	1.43% of 8-year-old girls identified with autism	2022 data across 16 U.S. surveillance sites, published in 2025; boys: 4.92%. This is not an estimate for adult women or every U.S. community (Shaw et al., 2025).
Postpartum depression	19.0% in 2021 in one large health system	2024 study of 442,308 births in Kaiser Permanente Southern California, 2010–2021. Diagnoses within the first postpartum year; not a national estimate (Khadka et al., 2024).
Schizophrenia	263.6 per 100,000 females globally	Age-standardized modeled prevalence in 2021, published January 2026; males: 291.6 per 100,000. This is roughly 0.264%, not a U.S. lifetime risk (Feng et al., 2026).
PTSD	5.2% of adult women in the past year	Historical U.S. 2001–2003 survey; men: 1.8% (NIMH, n.d.-f).
OCD	1.8% of adult women in the past year	Historical U.S. 2001–2003 survey; men: 0.5% (NIMH, n.d.-g).
Suicide deaths	5.6 deaths per 100,000 females in 2024	Final U.S. age-adjusted mortality rate, reported September 2026; males: 22.3. A mortality rate is not prevalence of suicidal thoughts or attempts (CDC NCHS, 2026).

These numbers describe groups, not an individual’s destiny. Low measured prevalence does not mean a condition is unimportant, and lower diagnosis rates can reflect missed recognition as well as genuine differences.

What recent research tells us

PMDD requires attention to timing

Reilly and colleagues’ 2024 systematic review and meta-analysis included 44 studies and 50,659 participants. Confirmed PMDD affected approximately 1.6% in community samples, compared with 3.2% across all confirmed-diagnosis samples. Provisional diagnoses produced higher estimates. This distinction matters because severe premenstrual distress deserves care, but a one-time questionnaire cannot establish the recurring pattern required for PMDD (Reilly et al., 2024).

PMDD can involve marked irritability, depression, anxiety, and impaired functioning before menstruation, with improvement after the period begins. Daily symptom tracking over at least two cycles helps distinguish PMDD from premenstrual worsening of an existing disorder. Treatment can include SSRIs, psychotherapy, and coordination with a gynecologic clinician when hormonal treatment is appropriate (ACOG, 2023).

Postpartum depression is common and treatable

Khadka and colleagues’ 2024 JAMA Network Open study found that postpartum depression diagnoses rose from 9.4% in 2010 to 19.0% in 2021 within Kaiser Permanente Southern California. The study covered 442,308 births. Improved screening and recognition may contribute to the observed increase, so the findings do not prove that the underlying illness itself doubled nationwide (Khadka et al., 2024).

Persistent sadness, loss of enjoyment, anxiety, guilt, and difficulty functioning after childbirth deserve assessment. Treatment should account for illness severity, sleep, support, pregnancy or breastfeeding, and any history of bipolar disorder. Medication decisions require an individualized discussion of treatment benefits, medication risks, and the risks of untreated illness (ACOG, n.d.).

Perimenopause can be a period of increased vulnerability

Badawy and colleagues’ 2024 meta-analysis found that perimenopausal women had higher odds of depressive symptoms or depression diagnoses than premenopausal women: an odds ratio of 1.40. That means 40% higher odds, not that 40% of women develop depression or that each woman’s absolute risk rises by 40% (Badawy et al., 2024).

Changes in mood, sleep, and concentration during this transition deserve evaluation rather than automatic dismissal as normal aging. Psychiatric care can be coordinated with primary care or gynecology to address both emotional symptoms and menopausal concerns. Perimenopausal depression is not a separate prevalence category that should be added to the depression figures above.

Autism may be overlooked in girls and women

Cruz and colleagues’ systematic review and meta-analysis, published online in January 2024 and in a 2025 journal issue, examined sex and gender differences in autism presentation and diagnostic procedures. Its findings support considering camouflaging and a broader range of presentations during assessment. A person may appear socially capable while spending substantial effort preparing conversations or managing sensory overload (Cruz et al., 2024).

This does not mean every socially exhausted woman is autistic. It means a thorough developmental history and careful assessment are more useful than stereotypes about what autism should look like.

How psychology differs between women and men

There is no single female psychology or male psychology. Group averages overlap, and gender alone cannot tell us someone’s personality, intelligence, emotional resilience, or treatment needs. Clinically useful differences concern patterns of risk, symptoms, life experiences, and recognition—not assumptions about character.

Biology and hormones are part of the picture

Menstrual cycling, pregnancy, childbirth, and menopause can influence mental health in susceptible people. Sex-related biology and gender-related experiences also interact with genetics and stress. A 2024 review in Translational Psychiatry describes these interacting influences in depression, anxiety, and PTSD. Hormones are one consideration; symptoms should not automatically be attributed to them (Singh & Wendt, 2024).

Stress and social experiences matter

Trauma exposure, safety, relationship experiences, discrimination, and socioeconomic circumstances can affect psychiatric risk. Caregiving and work demands may be relevant for a particular patient. These experiences vary greatly, and they should be explored rather than assumed from gender. Understanding the context helps clinicians avoid reducing a complex problem to a hormone level or diagnostic label (Singh & Wendt, 2024).

Symptoms and help seeking may look different

Women have higher measured rates of depression and many anxiety-related conditions in the surveys summarized above. Men have substantially higher suicide mortality. These patterns do not mean women are emotionally weaker or that men experience less distress. Sadness, anger, withdrawal, substance use, and physical complaints can occur in anyone. Assessment should ask about the full range of symptoms rather than rely on a gender stereotype (CDC NCHS, 2025; NIMH, n.d.-a; CDC NCHS, 2026).

Diagnostic expectations can hide neurodevelopmental conditions

ADHD in girls and women may involve inattention, disorganization, internal restlessness, and co-occurring anxiety or depression rather than conspicuous disruptive behavior. NIH notes that female ADHD is frequently underrecognized. Autism can also be missed when a person camouflages social difficulties. A good evaluation asks about childhood symptoms, school or work functioning, sensory needs, and the effort required to cope (Cruz et al., 2024; NIH DiscoverWHR, n.d.).

Research often uses female and male as binary categories and does not consistently distinguish sex from gender. The available statistics cannot fully describe transgender, nonbinary, or intersex people. Care should respect each patient’s identity while addressing relevant biology and lived experience (Singh & Wendt, 2024).

Other conditions deserve recognition

Bipolar disorder is more than ordinary mood swings. Distinct episodes of mania or hypomania require careful evaluation, including changes in sleep need, energy, activity, and judgment. Identifying bipolar disorder matters before choosing antidepressant treatment. Pregnancy and the postpartum period also require thoughtful planning for patients with bipolar illness (ACOG, n.d.; NIMH, n.d.-h).

Borderline personality disorder can involve intense emotional distress, unstable relationships or self-image, impulsivity, and self-harm. It is not a diagnosis that should be assigned simply because a woman is upset or has experienced trauma. Psychotherapy is the main treatment; dialectical behavior therapy is one established approach. Medications may address co-occurring conditions or specific symptoms, but they do not replace structured therapy (NIMH, n.d.-i).

Eating disorders can affect people at any body size. Restriction, binge eating, purging, or preoccupation with food and weight may require psychiatric treatment, nutritional support, and medical monitoring. Severe illness can require hospital or residential care (NIMH, n.d.-j).

PTSD and OCD can also affect women during pregnancy and after childbirth. Unwanted intrusive thoughts need careful assessment: an intrusive thought is not automatically an intention to act. OCD treatment may include exposure and response prevention, a specialized form of cognitive behavioral therapy, and medication when indicated (NIMH, n.d.-k).

Schizophrenia can affect women as well as men. Hallucinations, delusions, disorganized thinking, and declining functioning deserve prompt evaluation. A 2025 review describes differences in typical onset and treatment effects between women and men, while emphasizing the need for individualized care. Treatment commonly combines medication with psychological, family, and practical support (Moniem & Kafetzopoulos, 2025; NIMH, n.d.-l).

Sleep problems, substance use disorders, grief, and adjustment difficulties may coexist with any of these conditions. They belong in the assessment even when they are not the reason a patient initially seeks care.

How Turned Leaf Psychiatry can help

An evaluation that considers the whole person

We begin by listening to what has changed and how symptoms affect daily life. Assessment can include mood, anxiety, sleep, concentration, medication history, family history, substance use, and relevant medical concerns. When appropriate, we explore menstrual patterns, pregnancy or postpartum changes, and menopausal symptoms. Screening tools can support the evaluation, but an accurate diagnosis requires clinical judgment.

Personalized medication management

Our practice offers psychiatric medication management, including care for depression, anxiety, and ADHD. Treatment choices should reflect the diagnosis, prior response, side effects, other medications, and the patient’s goals. For women who are pregnant, breastfeeding, or planning pregnancy, coordination with the obstetric clinician is especially important. Follow-up allows treatment to be adjusted as needs change (ACOG, n.d.; Turned Leaf Psychiatry, n.d.).

Recognition of ADHD and autism

Turned Leaf Psychiatry offers ADHD testing and adult autism evaluations. For women who have spent years feeling overwhelmed, distracted, or socially exhausted, assessment may help clarify the source of those difficulties. Treatment and support should address functional needs and any co-occurring anxiety, depression, or sleep problems. Medication may help ADHD or co-occurring conditions; it does not cure autism (Turned Leaf Psychiatry, n.d.).

Therapy referrals and coordinated care

We can help patients identify appropriate psychotherapy and coordinate referrals when specialized care is needed. Depending on the diagnosis, that may include CBT, trauma-focused therapy, DBT for borderline personality disorder, or exposure and response prevention for OCD. Eating disorders may require a team that includes medical and nutritional care. A referral to intensive or hospital treatment is appropriate when outpatient care cannot safely meet a patient’s needs (NIMH, n.d.-i; NIMH, n.d.-j; NIMH, n.d.-k).

Accessible care and a practical next step

Turned Leaf Psychiatry offers in-person care in Ridgeland and telehealth across Mississippi. If symptoms are affecting your relationships, work, parenting, sleep, or enjoyment of life, you do not need to wait until they become a crisis to seek an evaluation (Turned Leaf Psychiatry, n.d.).

Call (601) 494-5503 or request an appointment. Our office is located at 199 Charmant Place, Suite 1, Ridgeland, Mississippi 39157 (Turned Leaf Psychiatry, n.d.).

When help is urgent

For suicidal thoughts or emotional crisis, call or text 988. If there is immediate danger, an overdose, or an inability to stay safe, call 911 or go to the nearest emergency department. New hallucinations, delusions, severe confusion, or mania after childbirth require emergency assessment. For additional support during or after pregnancy, call or text the National Maternal Mental Health Hotline at 1-833-852-6262. Routine appointment requests are not an emergency response service (CDC NCHS, 2026; ACOG, n.d.; NIMH, n.d.-m).

This article provides education and does not replace an individualized psychiatric or medical evaluation.